In 2018, Giannelou and colleagues were the first to report that TNF inhibitors could be used to treat SIFD, and no deaths were reported since then. The gene discussed is TNF; the disease is congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome.